Product How it works Pricing Blog FAQ About Contact
Gyre Therapeutics

Gyre Therapeutics (NASDAQ: GYRE) net income

Gyre Therapeutics reported a net profit of $9.9m for fiscal 2025, 44.8% less than in fiscal 2024 ($17.9m). Its net margin was 8.5%. Earnings per share were $0.06.

Gyre Therapeutics's best year of the last 10 was fiscal 2024. The biggest drop was in fiscal 2025, −44.8%. It reported a loss in 7 of those 10 years.

Net income, in millions of US dollars-16.92016-21.62017-30.12018-55.22019-56.22020-87.920214.32022-85.5202317.920249.92025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Net income by fiscal year

Fiscal yearNet incomeChangeNet marginEarnings per share
2025$9.9m−44.8%8.5%$0.06
2024$17.9m—16.9%$0.14
2023−$85.5m−2,081.5%−75.3%−$1.41
2022$4.3m—4.2%—
2021−$87.9m—−1,198.3%−$2.87
2020−$56.2m—−268.5%—
2019−$55.2m———
2018−$30.1m—−500,916.7%—
2017−$21.6m—−2,118.0%—
2016−$16.9m———

The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Gyre Therapeutics net income compared with its sector

By net income for its latest fiscal year, Gyre Therapeutics ranks 161st of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Gyre Therapeutics, 8.5%.

RankCompanyNet incomeNet margin
159thElectromed$11.3m15.3%
160thUtah Medical Products$11.3m29.3%
161stGyre Therapeutics$9.9m8.5%
162ndArtivion$9.8m2.2%
163rdLifeStance Health Group$9.7m0.7%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the net income of Gyre Therapeutics

How much did Gyre Therapeutics earn in fiscal 2025?
Gyre Therapeutics reported a net profit of $9.9m for fiscal 2025. In fiscal 2024 it reported a net profit of $17.9m.
What are the earnings per share of Gyre Therapeutics?
They were $0.06 in fiscal 2025, compared with $0.14 in fiscal 2024.
What is the net margin of Gyre Therapeutics?
In fiscal 2025 its net profit was 8.5% of its revenue.
What was the most profitable year for Gyre Therapeutics?
Of its last 10 fiscal years, fiscal 2024, with $17.9m.
Where does Gyre Therapeutics rank in its sector by net income?
It ranks 161st of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
Where do the figures for Gyre Therapeutics come from?
From the annual report (Form 10-K) that Gyre Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Gyre Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Gyre Therapeutics: the Gyre Therapeutics page · annual accounts · revenue · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.